Comparative Evaluation of Efficacy and Tolerability of Euphorbia Prostrata Extract in treatment of first & second degree hemorrhoids

Panacea Biotec Limited0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects with diagnosis of acute uncomplicated first degree external or internal hemorrhoids with active bleeding without infection and prolapse.
•Provided written informed consent.

•Presence of infection of anorectal region.
•Presence of other rectal pathology like anal fissure, rectal prolapse, ischiorectal abscess, anorectal fistula, or rectal polyp.
•Subjects with known hepatic or kidney diseases.
•Patients with known hypersensitivity to ingredients of study or comparator treatments
•Clinically significant co-morbid condition other than bleeding piles that could directly affect the efficacy & tolerability outcome of the study.
•Donated blood or plasma or participated in another clinical study with an investigational agent within 4 weeks preceding to enrollment.
•H/O drug/alcohol abuse.
•Pregnant and lactating women.
•Any other condition that, in the opinion of the investigator, does not justify the inclusion of the subject in the study.

发起方